8/10/23 16:11 | 8/8/23 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.d | 23 | 0.3859 | 0 | 60 | 107 | 116 | D | | | | | | | | | | | | | | |
8/10/23 16:11 | 8/8/23 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | S.d | -120 | 2.00 | 0 | -60 | -34 | 116 | D | | | | | | | | | | | | | | |
10/20/22 16:05 | 10/18/22 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.d | 6 | 0.3900 | 0 | 15 | 15 | 116 | D | | | | | | | | | | | | | | |
10/20/22 16:05 | 10/18/22 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | S.d | -175 | 11.70 | 0 | -15 | -11 | 116 | D | | | | | | | | | | | | | | |
9/22/22 16:40 | 9/20/22 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.d | 8 | 0.3900 | 0 | 20 | 21 | 116 | D | | | | | | | | | | | | | | |
9/22/22 16:40 | 9/20/22 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | S.d | -270 | 13.50 | 0 | -20 | -15 | 116 | D | | | | | | | | | | | | | | |
8/18/22 16:06 | 8/16/22 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.d | 31 | 0.3900 | 0 | 80 | 222 | 116 | D | | | | | | | | | | | | | | |
8/18/22 16:06 | 8/16/22 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | S.d | -1,011 | 12.64 | 0 | -80 | -41 | 116 | D | | | | | | | | | | | | | | |
2/8/22 16:05 | 2/7/22 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.d | 6 | 0.3900 | 0 | 15 | 15 | 116 | D | | | | | | | | | | | | | | |
11/10/21 16:05 | 11/9/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.d | 16 | 0.3900 | 0 | 40 | 66 | 101 | D | | | | | | | | | | | | | | |
7/15/21 16:01 | 7/13/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.dm | 12 | 0.3900 | 0 | 30 | 97 | 61 | D | | | | | | | | | | | | | | |
7/15/21 16:01 | 7/13/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | S.dm | -570 | 19.01 | 0 | -30 | -33 | 61 | D | | | | | | | | | | | | | | |
6/17/21 16:05 | 6/15/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.dm | 12 | 0.3900 | 0 | 30 | 97 | 61 | D | | | | | | | | | | | | | | |
6/17/21 16:05 | 6/15/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | S.dm | -659 | 21.97 | 0 | -30 | -33 | 61 | D | | | | | | | | | | | | | | |
5/25/21 18:29 | 5/25/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.d | 8 | 0.3900 | 0 | 20 | 49 | 61 | D | | | | | | | | | | | | | | |
5/13/21 16:43 | 5/11/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.dm | 12 | 0.3900 | 0 | 30 | 273 | 41 | D | | | | | | | | | | | | | | |
5/13/21 16:43 | 5/11/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | S.dm | -597 | 19.90 | 0 | -30 | -42 | 41 | D | | | | | | | | | | | | | | |
4/15/21 17:53 | 4/13/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.dm | 12 | 0.3900 | 0 | 30 | 273 | 41 | D | | | | | | | | | | | | | | |
4/15/21 17:53 | 4/13/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | S.dm | -734 | 24.46 | 0 | -30 | -42 | 41 | D | | | | | | | | | | | | | | |
2/18/21 17:49 | 2/16/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.dm | 115 | 3.72 | 0 | 31 | 312 | 41 | D | | | | | | | | | | | | | | |
2/18/21 17:49 | 2/16/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | S.dm | -925 | 29.81 | 0 | -31 | -43 | 41 | D | | | | | | | | | | | | | | |
1/21/21 17:31 | 1/19/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | M.dm | 113 | 3.33 | 0 | 34 | 486 | 41 | D | | | | | | | | | | | | | | |
1/21/21 17:31 | 1/19/21 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | D | | S.dm | -630 | 21.01 | 0 | -30 | -42 | 41 | D | | | | | | | | | | | | | | |
12/17/20 18:01 | 12/15/20 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.dm | 112 | 3.72 | 0 | 30 | 429 | 37 | D | | | | | | | | | | | | | | |
12/17/20 18:01 | 12/15/20 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.dm | -586 | 19.53 | 0 | -30 | -45 | 37 | D | | | | | | | | | | | | | | |
3/16/20 07:00 | 3/13/20 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 1 | 0.3900 | 0 | 3 | 9 | 37 | D | | | | | | | | | | | | | | |
1/24/20 16:59 | 1/23/20 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 2 | 0.3900 | 0 | 6 | 21 | 34 | D | | | | | | | | | | | | | | |
1/17/19 17:52 | 1/17/19 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 4 | 0.3900 | 0 | 9 | 47 | 28 | D | | | | | | | | | | | | | | |
11/16/18 17:17 | 11/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 19 | 3.72 | 0 | 5 | 36 | 19 | D | | | | | | | | | | | | | | |
11/16/18 17:17 | 11/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -199 | 39.84 | 0 | -5 | -21 | 19 | D | | | | | | | | | | | | | | |
10/15/18 17:54 | 10/11/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.dm | 23 | 1.50 | 0 | 15 | 375 | 19 | D | | | | | | | | | | | | | | |
10/15/18 17:54 | 10/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -208 | 41.53 | 0 | -5 | -21 | 19 | D | | | | | | | | | | | | | | |
9/19/18 19:08 | 9/17/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 19 | 3.72 | 0 | 5 | 125 | 9 | D | | | | | | | | | | | | | | |
9/19/18 19:08 | 9/17/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -332 | 66.31 | 0 | -5 | -36 | 9 | D | | | | | | | | | | | | | | |
8/17/18 14:59 | 8/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 19 | 3.72 | 0 | 5 | 125 | 9 | D | | | | | | | | | | | | | | |
8/17/18 14:59 | 8/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -279 | 55.88 | 0 | -5 | -36 | 9 | D | | | | | | | | | | | | | | |
7/17/18 16:01 | 7/16/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 19 | 3.72 | 0 | 5 | 125 | 9 | D | | | | | | | | | | | | | | |
7/17/18 16:01 | 7/16/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -210 | 42.06 | 0 | -5 | -36 | 9 | D | | | | | | | | | | | | | | |
5/31/18 16:22 | 5/31/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 4 | 0.3900 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
5/16/18 13:37 | 5/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 28 | 3.72 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
5/16/18 13:37 | 5/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -347 | 46.28 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
4/17/18 12:20 | 4/16/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 28 | 3.72 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
4/17/18 12:20 | 4/16/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -270 | 36.00 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
3/16/18 10:09 | 3/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 28 | 3.72 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
3/16/18 10:09 | 3/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -286 | 38.20 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
2/16/18 11:54 | 2/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 28 | 3.72 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
2/16/18 11:54 | 2/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -150 | 20.00 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
1/17/18 09:48 | 1/16/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 28 | 3.72 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
1/17/18 09:48 | 1/16/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -172 | 22.99 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
12/20/17 08:48 | 12/18/17 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | M.d | 28 | 3.72 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
12/20/17 08:48 | 12/18/17 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Velleca Mark A. | NC | DO | P,CEO | S.d | -150 | 20.01 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |